Samuel Waksal, the former CEO of ImClone who was made famous when he went to prison for an insider trading scheme involving home crafts maven Martha Stewart, is out and ready to try again, reports the New York Times' Andrew Pollack. Less than two years after being released from prison, Waksal has started a new biotech company called Kadmon Pharmaceuticals, which he says will have "significant revenues," five Phase 3 products, and a couple of Phase 2 products by next year.